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Introduction: 3-Nitropropionic acid (3-NP), a mitochondrial toxin, induces 
the acute hearing loss by impairing mitochondrial energy generation. 
Resveratrol is known to have potent protective effects against ototoxicity from 
various sources as an antioxidant. The aim of the present study is to 
investigate the protective effect of resveratrol against 3-NP-induced acute 
cochlear damage. 
 
Methods: Fifteen male Sprague-Dawley rats were divided into 3 groups. In 
group A, the 3-NP (500 mM, 4 μl, intratympanically) was injected, and in 
group B, only resveratrol (10 mg/kg, 5 days, intraperitoneally) was 
administered. In group C, resveratrol pretreatment (10 mg/kg, 5 days, 
intraperitoneally) was performed before 3-NP injection. The auditory 
brainstem response (ABR) was recorded at 8, 16, and 32 kHz before and after 
treatment. And, 4 weeks after treatment, the histological analysis of cochleae 
from each group was performed to investigate changes of cochlear cells. 
 
Results: After 3-NP exposure (group A), ABR thresholds were significantly 
elevated compared to those treated with only resveratrol (group B) which 
showed normal findings. However, resveratrol pretreatment before 3-NP 
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exposure (group C) led to a significant decrease of ABR thresholds. 
Histological analysis of group A revealed loss of fibrocytes in the spiral 
ligament (SL), hair cells and supporting cells in the organ of Corti, stellate 
fibrocytes and interdental cells in the spiral limbus, and spiral ganglion (SG) 
cells, whereas group B and C demonstrated normal findings. In addition, the 
thickness of stria vascularis in group A and C were decreased compared to 
that in group B, and that of group A was the thinnest. When investigating the 
cell counts of the fibrocytes in SL and the ganglion cells in SG area, those of 
group A was significantly decreased compared to those in group B and C. 
Conclusions: These results suggest that resveratrol may have a protective 







Keywords: Resveratrol, 3- nitropropionic acid, ototoxicity 




Abstract .......................................................................................................... i 
Contents ....................................................................................................... iii 
List of tables and figures ............................................................................. iv 
List of abbreviations .................................................................................. vii 
 
Introduction .................................................................................................. 1 
Material and Methods .................................................................................. 2 
Results ............................................................................................................ 6 
Discussion .................................................................................................... 25 
Conclusion ................................................................................................... 30 
References .................................................................................................... 31 




LIST OF TABLES AND FIGURES 
 
Fig. 1-1. Mean auditory brain response (ABR) thresholds before treatment in 
group A, B, and C. Mean ABR threshold in each group was not significantly 
different at 8 and 16 kHz (p = 0.959 and 0.783, respectively) whereas at 32 
kHz, mean ABR threshold in group C was significantly higher than group B. 
(p = 0.008) 
Fig.1-2. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 1 week after treatment in group A, B, and C. ABR thresholds 
in group A and C were significantly elevated. There were significant 
differences of mean ∆ABR thresholds in group A and C in comparison with 
those in group B at 8, 16 and 32 kHz. (p < 0.001, 0.001, and 0.002 for group A 
and B, and p = 0.006, 0.006, and 0.012 for group B and C at each frequency) 
There was no significant difference between group A and C at all frequencies. 
Fig.1-3. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 2 weeks after treatment in group A, B, and C. Mean ∆ABR 
thresholds in group C were statistically smaller at 8 and 16 kHz compared 
with those in group A. (p = 0.013 and 0.025, respectively) Mean ∆ABR 
thresholds between group B and C at 8, 16 and 32 kHz showed a significant 
difference. (p = 0.006, 0.015, and 0.026, respectively) 
Fig.1-4. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 4 weeks after treatment in group A, B, and C. At 8, 16 and 
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32 kHz, there were significant differences of mean ∆ABR thresholds between 
group A and C. (p = 0.006, 0.006, and 0.049, respectively) 
Fig.2-1. Group A : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. Loss of all types of fibrocytes in the 
spiral ligament and the atrophy of stria vascularis are shown. (arrow) 
Fig.2-2. Group B : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. The density of fibrocytes and the 
thickness of stria vascularis show normal findings.  
Fig.2-3. Group C : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. The fibrocytes and stria vascularis 
demonstrate preserved findings compared with those of group A. (arrow)  
Fig.2-4. The comparison of average thickness of the stria vascularis among 3 
groups. There are statistically significant differences among groups. 
Fig.2-5. Average cell counts among 3 groups in fibrocyte region in the spiral 
ligament (SL). Group A showed a statistically significant decrease in cell 
counts than group B and C in the SL. 
Fig.3-1. Group A : Hematoxylin and eosin-stained finding of organ of Corti 
(OC) in the second cochlear turn. Loss of most hair cells and supporting cells 
in OC and stellate fibrocytes in the limbic central zone of the spiral limbus is 
observed. 
Fig.3-2. Group B : Hematoxylin and eosin-stained finding of organ of Corti in 
vi 
 
the second cochlear turn. Normal cell distribution is found. 
Fig.3-3. Group C : Hematoxylin and eosin-stained finding of organ of Corti 
(OC) in the second cochlear turn. Hair cells and supporting cells in OC and 
stellate fibrocytes in the limbic central zone of the spiral limbus are well 
preserved. 
Fig.4-1. Group A : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Severe degeneration of 
SG cells is shown.  
Fig.4-2. Group B : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Normal SG cell 
population is observed. 
Fig.4-3. Group C : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Preservation of SG 
cells is observed. 
Fig.4-4. Average cell counts among 3 groups in spiral ganglion (SG). Group A 
showed a statistically significant decrease in cell counts than group B and C in 
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Mitochondria produce ATP, the primary source of cellular energy, and their 
acute damage may induce an energy failure-related acute hearing loss. 3-
nitropropionic acid (3-NP) known to be a mitochondrial toxin causing an 
oxidative damage, is a neurotoxin produced by some fungal species and an 
irreversible inhibitor of succinate dehydrogenase. (1) A recent study showed 
that the rat treated with 3-NP in the cochlea had a severe hearing loss by the 
cellular degeneration in the cochlear lateral wall. (2) In addition, the possible 
source of oxidative stresses was thought to be the mitochondrial dysfunction. 
(3)  
Resveratrol is a kind of natural polyphenolic compound found in various food 
products, with particularly high levels present in grape skins (50–100 µg/g) 
and red wine (1.52 mg/l). (4)  It is well known to have antioxidative and 
anti-inflammatory effect. (5, 6) Some researchers reported that resveratrol 
modulates the lipid and lipoprotein metabolism, inhibits platelet aggregation, 
and also has immunomodulatory properties and vasorelaxing activity. (7) On 
otologic field, there were some reports about its antineoplastic activity and 
hearing preservation against the ototoxic agents or noise. (4, 8-12) 
The present study was performed to investigate whether resveratrol 
pretreatment can protect the cochlea against the acute cochlear damage that 
occurs after local administration of 3-NP.  
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Materials and methods 
 
Animal preparation and care 
This study was carried out under approval of the Institutional Animal Care 
and Use Committee of Seoul National University Hospital Biomedical 
Research Institute. (IACUC 13-0234-C0A2-1) Fifteen 4-week-old male 
Sprague-Dawley rats were prepared. Light and dark periods, room 
temperature, and humidity were controlled strictly. The external ear canals 
and tympanic membranes of all animals were examined by a researcher and 
there was no evidence of otitis externa, tympanic membrane perforation or 
middle ear infection in any rats. 
 
Drug preparation 
Resveratrol (Sigma-Aldrich Corp., St. Louis, MO, USA) was dissolved in 
saline (pH 7.4) at 10 mg/ml. As an ototoxic agent, 3-NP (Sigma, St. Louis, 
MO, USA) was dissolved in saline (pH 7.4) at 500 mM. 
 
Treatment 
Fifteen rats were randomly divided into three groups, each group was 
composed of 5 rats. As one rat in group C was dead, further studies were 
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performed with 14 rats. In group A (n=5), only 3-NP was administrated. In 
group B (n=5), only resveratrol was administrated and animals in group C 
(n=4) were treated with both 3-NP and resveratrol.  
Animals of group A were treated with 500 mM of 3-NP intratympanically 
using 1 cc syringe with 26 G spinal needle under microscopy. For animals of 
group B and C, 10 mg/kg of resveratrol was administrated intraperitoneally 
for 5 days. At the third day of administration, 500 mM of 3-NP was injected 
intratympanically for animals of group C. 
 
Auditory brainstem response (ABR) measurement 
ABR was recorded before and 1, 2 and 4 weeks after administration. Each 
animal was anesthetized with Tiletamine/Zolazepam (1:1) (10 mg/kg) and 
xylazine (5 mg/kg). External auditory canals were examined before ABR 
recording. Tone-burst sounds (8, 16, and 32 kHz) were measured by SmartEP 
(Intelligent Hearing Systems version 3.30 program, Intelligent Hearing 
Systems, Miami, FL). Hearing threshold was defined as the lowest stimulus 
intensity level that showed a reliable waveform in the ABR trace by the visual 
inspection of one investigator. 
 
Histopathology 
Four weeks after administration, the rats were sacrificed under deep 
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anesthesia. Cochleae of all groups were harvested. After overnight fixation 
with 10% formaline in 0.1 M phosphate-buffered saline, decalcification was 
done with 10% ethylenediamine tetraacetic acid in 0.1 M phosphate-buffered 
saline. After rinsing with 0.1 M phosphate-buffered saline, the tissues were 
prepared as a frozen block and cut into 10 µm thick sections. Hematoxylin 
and eosin staining was performed for histological anaylsis. 
Histological examination was done 4 weeks after administration in the lateral 
wall, organ of Corti (OC), and spiral ganglion (SG) area of all groups. Under 
the microscopic examination, the quantitative analysis was done for 5 samples 
per each area of each group. The average thickness of stria vascularis (SV) 
was measured in the manner described by Wangemann et al. (13) The 
thickness was determined by the average of three points determined evenly in 
the whole SV. The cell counting was done for the fibrocytes in the spiral 
ligament (SL) and SG cells in the SG area. The unit areas were 10,000 ㎛2 
and 2,500 ㎛2, respectively. The cell count was determined by the average of 
cell counts in two unit areas per one sample. 
Olympus BX51 microscope was used for microscopic examination and 
measurement of the thickness of SV and cell counting. 
 
Statistical analysis 
Data were analyzed with SPSS version 15.0 (SPSS Inc., Chicago, IL). The 
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Mann-Whitney U test and Kruskal-Wallis 1-way analysis were used to 
examine differences of ∆ABR thresholds, the thickness of SV, and the cell 







ABR threshold shift 
ABR was measured in 14 rats except for 1 died. In pretreatment examination, 
mean ABR threshold in each group was not significantly different at 8 and 16 
kHz (p = 0.959 and 0.783, respectively) whereas at 32 kHz, mean ABR 
threshold in group C was significantly higher than group B. (Fig.1-1, p = 
0.008) One week after administration of 3-NP and/or resveratrol, there were 
significant differences of mean ∆ABR thresholds in group A and C in 
comparison with those in group B in all frequencies. (Fig.1-2, p < 0.001, 
0.001, and 0.002 for group A and B, and p = 0.006, 0.006, and 0.012 for group 
B and C in each frequency.) There was no significant difference between 
group A and C in all frequencies. Two weeks after treatment, mean ∆ABR 
threshold at each frequency in group C showed a tendency of recovery. (Fig.1-
3) Mean ∆ABR thresholds at 8 and 16 kHz between group A and C were 
statistically significant (p = 0.013 and 0.025, respectively), however, not at 32 
kHz. (p = 0.163) And the improvement was still limited and there was 
significant difference of ∆ABR between group B and C at 8, 16, and 32 kHz. 
(p = 0.006, 0.015, and 0.026, respectively) Four weeks after treatment, further 
recovery of mean ABR threshold in group C was observed. (Fig.1-4) At 8, 16, 
and 32 kHz, there were significant differences of mean ∆ABR threshold in 
group C in comparison with group A. (p = 0.006, 0.006, and 0.049, 
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respectively) And, there were no significant differences between group B and 
C in all frequencies. (p = 0.145, 0.387, and 0.437, at 8, 16, and 32 kHz) 
 
Histological analysis  
Histological examination was done in second cochlear turns among all groups. 
In lateral wall of cochlea, group A revealed loss of all types of fibrocytes in 
the SL and the atrophy of SV, while group B showed normal findings and 
group C less severe findings than that of group A. (Fig.2-1, 2-2, 2-3) The 
average thickness of the SV was 8.0 µm, 21.5 µm, and 16.1 µm, respectively. 
There are statistically significant differences among groups. The SV in group 
C was significantly thinner than group B, however there was also a significant 
difference between the thickness in group A and C. (Fig.2-4) The average cell 
counts of the fibrocytes in the SL were 2.6, 17.1, and 15.8, respectively. 
Group A showed a statistically significant decrease of cell counts in the SL 
compared with group B and C. (Fig.2-5) 
In the OC area, group A showed the loss of most hair cells and supporting 
cells in the OC and stellate fibrocytes and interdental cells of the spiral limbus. 
(Fig.3-1) On the other hand, group B demonstrated normal findings and most 
cells in the OC area in group C were preserved. (Fig.3-2, 3-3) 
In the SG area, group A demonstrated the severe degeneration of SG cell. 
(Fig.4-1) In group B, normal SG cell population was observed. (Fig.4-2) In 
group C, the degeneration of SG cells was not as severe as that of group A. 
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(Fig.4-3) The average cell counts in the SG area were 19.6, 36.8, and 36.7, 
respectively. Group A showed a statistically significant decrease of cell counts 





Fig. 1-1. Mean auditory brain response (ABR) thresholds before treatment in 
group A, B, and C. Mean ABR threshold in each group was not significantly 
different at 8 and 16 kHz (p = 0.959 and 0.783, respectively) whereas at 32 
kHz, mean ABR threshold in group C was significantly higher than group B. 



































Fig.1-2. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 1 week after treatment in group A, B, and C. ABR thresholds 
in group A and C were significantly elevated. There were significant 
differences of mean ∆ABR thresholds in group A and C in comparison with 
those in group B at 8, 16 and 32 kHz. (p < 0.001, 0.001, and 0.002 for group A 
and B, and p = 0.006, 0.006, and 0.012 for group B and C at each frequency) 



































Fig.1-3. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 2 weeks after treatment in group A, B, and C. Mean ∆ABR 
thresholds in group C were statistically smaller at 8 and 16 kHz compared 
with those in group A. (p = 0.013 and 0.025, respectively) Mean ∆ABR 
thresholds between group B and C at 8, 16, and 32 kHz showed a significant 

































Fig.1-4. Mean ∆auditory brain response (∆ABR) thresholds between 
pretreatment and 4 weeks after treatment in group A, B, and C. At 8, 16, and 
32 kHz, there were significant differences of mean ∆ABR thresholds between 

































Fig.2-1. Group A : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. Loss of all types of fibrocytes in the 




Fig.2-2. Group B : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. The density of fibrocytes and the 




Fig.2-3. Group C : Hematoxylin and eosin-stained histological finding in the 
lateral wall of the second cochlear turn. The fibrocytes and stria vascularis 





Fig.2-4. Average thickness of the stria vascularis among 3 groups. There are 




Fig.2-5. Average cell counts among 3 groups in fibrocyte region in the spiral 
ligament (SL). Group A showed a statistically significant decrease in cell 




Fig.3-1. Group A : Hematoxylin and eosin-stained finding of organ of Corti 
(OC) in the second cochlear turn. Loss of most hair cells and supporting cells 






Fig.3-2. Group B : Hematoxylin and eosin-stained finding of organ of Corti in 





Fig.3-3. Group C : Hematoxylin and eosin-stained finding of organ of Corti 
(OC) in the second cochlear turn. Hair cells and supporting cells in OC and 






Fig.4-1. Group A : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Severe degeneration 





Fig.4-2. Group B : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Normal SG cell 






Fig.4-3. Group C : Hematoxylin and eosin-stained histological finding in the 
spiral ganglion (SG) cells of the second cochlear turn. Preservation of SG 





Fig.4-4. Average cell counts among 3 groups in spiral ganglion (SG). Group A 
showed a statistically significant decrease in cell counts than group B and C in 







Homeostasis in the cochlear fluid and generation of the endocochlear potential 
are essential for the maintenance of cochlear function. Potassium ion (K
+
) 
known to be the major charge carrier for the generation of the endocochlear 
potential requires changes of gradient for the ion channel activation. To 
maintain the K
+
 gradient and its recycling, there are two independent gap 
junction systems in the cochlea. (14) One system is the connective tissue gap 
junction system. K
+
 is taken up from perilymph by fibrocytes in the SL and 
diffuses into intermediate cells in the SV. The intermediate cells mainly 
generate the endocochlear potential by relieving K
+
 into the intrastrial fluid. 
Then, K
+
 in the intrastrial fluid is removed by the strial marginal cells to 
maintain K
+
 gradient in the cochlea. The other system is the epithelial gap 
junction system. K
+
 within the hair cells in the OC is taken up by supporting 
cells in the OC and then, moves toward the interdental cells in the spiral 
limbus and root cells within the SL. (15, 16) K
+
 recycling is regulated by 
active K
+
 transport. (17) Therefore, the ATP depletion induced by toxic agents 
including 3-NP and the resultant the disturbance of cochlear homeostasis and 
abolishment of endocochlear potential can cause a sensorineural hearing loss. 
Various methods for the establishment of hearing loss animal model by the 
administration of 3-NP have been introduced. (2, 15, 17-23) Initially, the 
approach through round window niche (2, 18, 21, 23) was tried and thereafter 
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approaches via round window membrane (17), cochleostomy (15), and 
posterior semicircular canal (19) were reported. Recently, the intratympanic 
injection of 3-NP also showed the significant increase of hearing thresholds. 
(20, 22) The intratympanic injection has some advantages compared with 
other administration methods. That is, the injection technique is simple and 
minimally invasive, therefore the mechanical damage to the intracochlear 
structure may be prevented. However, if the intratympanic administration of 
3-NP is decided, the delivery of the protective agent using the same 
administration route should be avoided because 3-NP induces the severe 
proliferation of mucosa in the middle ear cavity. 
The present study also showed the thinning of SV and degeneration of the 
fibrocytes in the SL, hair cells and supporting cells in OC, and ganglion cells 
in the SG area. By the diffusion of 3-NP into the cochlea, acute mitochondrial 
dysfunction and the resultant histological changes in the cochlea can be 
induced. (18) Fibrocytes in the SL were known to be the major susceptible 
structure to 3-NP exposure. (18) And, some authors reported that 3-NP also 
induced the loss of outer hair cells in the OC and/or the degeneration of SG 
cell. (15, 19, 24) Changes of endolymphatic potential in the area were thought 
to be the cause for cellular degenerations. (19)  
Recently, there were some studies reporting the protective effect of resveratrol 
against several ototoxic stimuli. (5, 11, 25-27) Seidman et al. suggested that 
resveratrol had a protective effect on noise-induced hearing loss. (11, 25) 
Other researchers have reported that resveratrol showed the protective effect 
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against ototoxicity induced by cisplatin. (4, 26, 27) The main mechanism of 
protection by resveratrol suggested in some studies was thought to be the anti-
oxidative property of resveratrol by the down-regulation of Cyclooxygenase-2 
expression. (25) In previous some studies, resveratrol was administrated 
before exposure to ototoxic stimuli (11, 27), whereas other authors 
administered resveratrol both before and after exposure to the stimuli (4, 25, 
26). In the present study, 3-NP was injected in the middle of administration 
periods (5 days) of resveratrol to evaluate the protective effect of resveratrol 
against acute cochlear damage by 3-NP as well as its preventive effect. 
The main route into the cochlea of intratympanically delivered ototoxic agents 
is thought to be through the round window. Therefore, the hearing loss 
induced by ototoxic agents will mainly affect high frequency ranges. In this 
study, however, the ABR threshold at the high frequency after 3-NP injection 
was not severe compared to those at 8 and 16 kHz. High dose of ototoxic 
agents exceeded a maximum limit of hearing thresholds and there was no 
significant difference in degrees of hearing loss at each frequency. (18, 19) 
The present study showed the big shift of ABR thresholds at 8 and 16 kHz in 
group C treated with resveratrol and 3-NP injection. This finding may be 
explained by that the restoration of ABR threshold at the high frequency may 
be disturbed due to more toxic effect of 3-NP around the round window 
membrane. 
The present study investigated the functional restoration and structural 
preservation of the cochlea after administration of resveratrol in 3-NP-induced 
3p Resveratrol 
소개, 효과, 기
전, 투여시기  
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hearing loss. One week after administration of 3-NP and resveratrol, group C 
showed elevated ABR threshold. However, two and four weeks after 
administration, this group revealed a progressive recovery of ABR thresholds. 
By the analogy from this result, resveratrol may play a role of cellular 
protection or restoration in the cochlea. The effect of resveratrol 
administration after ischemic damage was also reported in the neurovascular 
injury model. (28)  
With the administration of resveratrol, the fibrocytes in SL, the hair cells in 
OC, and the ganglion cells in SG area showed almost normal findings. And, 
cell counting analysis in the area also demonstrated consistent results. 
Therefore, when considering with results of ABR and histological analysis, 
resveratrol seems to initiate main restorative action for the cellular function 
between 1 and 4 weeks after intracochlear diffusion of 3-NP. The present 
study also showed that the thickness of SV in group C was more normal than 
in 3-NP only group. However, this finding in group C was significantly 
thinner than the thickness in group B, resveratrol only group. The SV is one of 
main structures responsible for endolymphatic homeostasis and ototoxic 
stimuli to the SV is known to induce a temporary reduction of endolymphatic 
potential and transient hearing loss even without the damage of the OC. (29, 
30) And, it was reported that the residual shrinkage of SV after damage 
persists even after the endolymphatic potential recovers. (29) In the present 
study, the atrophic finding in the SV in group C may be a form recovered 




Although there was no study with 3-NP and resveratrol in the otological field 
before this study, some authors have reported the neuroprotective effect of 
resveratrol against a neurodegenerative model in brain induced by 3-NP in 
neurological field. (3, 31, 32) In the Huntington’s disease model induced by 3-
NP, they suggested that the motor and cognitive impairment could be reversed 
with repeated administration of resveratrol for 8 days. 
For further evaluation, immunocytochemistry and/or molecular biologic 
analysis for the investigation of the detailed protective mechanism of 
resveratrol is needed. Because resveratrol is present in various kinds of foods 
like red wine and grape skin, and peanut, the clinical application of resveratrol 
may be very easy and effective if the therapeutic value of resveratrol is proved 






Administration of resveratrol showed a functional and morphological 
restoration from 3-NP-induced acute cochlear damage. Resveratrol may play a 
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서론: 미토콘드리아 독소로 알려진 3-nitropropionic acid (3-
NP)는 미토콘드리아의 에너지 생성 기능의 손상에 의한 급성 
난청을 유발한다. Resveratrol은 항산화물질로서 다양한 종류의 
이독성 손상으로부터 강력한 보호효과를 가지는 것으로 알려져 
있다. 이 연구의 목적은 3-NP로 인해 유발된 급성 와우 손상에 
대한 resveratrol의 보호 효과를 관찰하는 것이다. 
 
재료 및 방법: 15마리의 수컷 Sprague-Dawley rat을 세 개의 
군으로 분류하였다. A군에서는 3-NP (500 mM, 4 μl) 를 고실내 
주입하였고, B군에서는 resveratrol (10 mg/kg) 을 5일간 복강 내 
주입하였다. C군에서는 3-NP 고실내 주입 전 resveratrol 전처치 
(10 mg/kg, 5일, 복강내 주입) 을 시행하였다. 약물 주입 전후로 8, 
16, 32 kHz에서 청성뇌간반응을 측정하였다. 와우의 세포변화를 
관찰하기 위하여 약물 주입 4주 후, 각 군에서 와우의 조직학적 
분석을 시행하였다. 
 
결과: 3-NP를 투여한 A군의 청성뇌간반응역치는 정상소견을 보인 
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B군에 비해 의미있게 증가한 소견을 보였다. 그러나 3-NP 고실내 
주입 전 resveratrol을 투여한 C군에서는 청성뇌간반응역치의 유의
한 감소가 관찰되었다. A군의 조직학적 검사에서 나선인대의 섬유세
포, 코르티 기관의 유모세포와 지지세포, 나선연의 성상 섬유세포와 
치간세포, 나선신경절 세포수의 감소가 관찰되었으나 B군과 C군에
서는 정상소견을 보였다. 또한 A군과 C군에서의 혈관조의 두께는 
B군에 비해 감소된 소견을 보였으며, 그 중에서도 A군의 혈관조 두
께가 가장 얇았다. 나선인대의 섬유세포와 나선신경절의 신경절세포
수는 A군이 B군 및 C군과 비교하여 의미있게 감소했다. 
 
결론: 본 연구결과 resveratrol은 3-NP로 인한 급성 와우 손상에 
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